Purchase Order 1232SA25P0440
Award Date 3/1/25
Potential Completion Date 3/4/26
Potential Value $39K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by a civilian federal agency to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for a Qiagen Ingenuity Pathway Analysis (IPA) Limited Concurrent License, which is used to identify and predict master regulators that may have otherwise been overlooked, and to quickly understand diseases, phenotypes, associated genes, and other relevant insights. The contract has a ceiling value of $39,252.00...
- This is a firm fixed-price purchase order contract award by the U.S. Army Corps of Engineers (USACE) to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $90,325.61 contract is for a 1-year software license for the Ingenuity Pathways Analysis (IPA) system, which supports biomedical research, public health, and healthcare programs. The contract was awarded on a sole-source basis without any set-aside designations. Qiagen provides a variety of molecular diagnostics...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC for software licenses for NIDDK's IPA (Ingenuity Pathway Analysis) software. The contract has a ceiling value of $31,733.00 and a period of performance through September 28, 2025. Qiagen is a global provider of molecular diagnostics, applied testing, and bioinformatics...
- The Defense Health Agency awarded a $167,309.55 firm fixed-price purchase order to Qiagen, LLC for Ingenuity Pathway Analysis (IPA) software licenses on September 17, 2025. The contract, with an ultimate completion date of September 16, 2030, represents a non-set-aside award to the foreign-owned molecular diagnostics and bioinformatics company headquartered in Germantown, Maryland. IPA software is a bioinformatics analysis platform used for interpreting genomic data and pathway analysis,...
- This is a firm fixed-price purchase order contract awarded by the Northeast Area of a civilian federal agency to Qiagen, LLC, a division of Qiagen N.V. The contract is for the provision of IPA (Ingenuity Pathway Analysis), a functional genomic analysis software, which will be shared with five systems at the Beltsville Agricultural Research Center (BARC). The contract has a ceiling value of $31,733.00 and a completion date of February 28, 2025. Qiagen is a global provider of sample and assay...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed-price purchase order to Qiagen, LLC, a division of the international provider Qiagen N.V., to provide IPA (Ingenuity Pathway Analysis) Analysis Match Explorer CL software licenses. The contract has a potential value of $139,495.00 and a performance period ending on August 31, 2023. This award does not utilize any set-aside designations. Qiagen has a history of...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC. The contract is for 4 annual licenses of Qiagen's IPA (Ingenuity Pathway Analysis) advanced analytics software, with a total ceiling value of $99,750.00. The contract does not have a set-aside designation. Qiagen is an international provider of sample and assay technologies, and has...
- The U.S. government awarded a $64,803.10 firm fixed-price purchase order to Qiagen, LLC on August 1, 2024, for IPA Analysis Match Explorer add-user licensing in production environments. This contract, which is a child order under a larger vehicle, will be performed in Germantown, Maryland, where Qiagen maintains its headquarters, with an ultimate completion date of March 2, 2029. The award was made by a civilian federal agency within the Northeast Area and did not utilize a set-aside...
- The Department of Health and Human Services' National Institutes of Health National Institute of Environmental Health Sciences awarded a $192,095.00 firm fixed price purchase order to Qiagen, LLC to provide 5 software support license renewals for Ingenuity Pathway Analysis (IPA) software. The contract has a completion date of December 31, 2022 and does not have a set-aside designation. Qiagen, LLC is a division of the international provider Qiagen N.V., which has a history of providing a range...
- This is a $22,536 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The contract is for IPA (Ingenuity Pathway Analysis) software licenses and LCL (local community) group licenses. Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academic research, and has held numerous federal...